India is quite good at pharmaceuticals -- their generics basically serve the rest of the world that are priced out of US-made products IIRC.
Ex. their generic version of Paxlovid:
https://www.reuters.com/business/healthcare-pharmaceuticals/...
Basically, with the expiring patents coming up on a bunch of these drugs:
https://www.biospace.com/article/9-drugs-losing-patents-or-e...
We're going to be in interesting waters soon.